These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 35909556)

  • 1. Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites.
    Wang D; Liu J; Zhou L; Zhang Q; Li M; Xiao X
    Front Endocrinol (Lausanne); 2022; 13():905171. PubMed ID: 35909556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.
    Zhou Z; Sun B; Yu D; Zhu C
    Front Cell Infect Microbiol; 2022; 12():834485. PubMed ID: 35242721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus.
    Wu J; Yang K; Fan H; Wei M; Xiong Q
    Front Endocrinol (Lausanne); 2023; 14():1114424. PubMed ID: 37229456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus.
    Du L; Li Q; Yi H; Kuang T; Tang Y; Fan G
    Biomed Pharmacother; 2022 May; 149():112839. PubMed ID: 35325852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral metformin on gut microbiota characteristics and metabolite fractions in normal-weight type 2 diabetic mellitus patients.
    Niu X; Wang Y; Huang L; Guo P; Zhang S; Sun Y; Jin M
    Front Endocrinol (Lausanne); 2024; 15():1397034. PubMed ID: 39257903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential.
    Hasain Z; Mokhtar NM; Kamaruddin NA; Mohamed Ismail NA; Razalli NH; Gnanou JV; Raja Ali RA
    Front Cell Infect Microbiol; 2020; 10():188. PubMed ID: 32500037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus.
    Liu W; Luo Z; Zhou J; Sun B
    Front Cell Infect Microbiol; 2022; 12():853771. PubMed ID: 35711668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions Between Gut Microbiota, Host, and Herbal Medicines: A Review of New Insights Into the Pathogenesis and Treatment of Type 2 Diabetes.
    Zheng Y; Gou X; Zhang L; Gao H; Wei Y; Yu X; Pang B; Tian J; Tong X; Li M
    Front Cell Infect Microbiol; 2020; 10():360. PubMed ID: 32766169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating the Gut Microbiota and Metabolites with Traditional Chinese Medicines: An Emerging Therapy for Type 2 Diabetes Mellitus and Its Complications.
    Jiang P; Di Z; Huang W; Xie L
    Molecules; 2024 Jun; 29(12):. PubMed ID: 38930814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut-targeted therapies for type 2 diabetes mellitus: A review.
    Xu TC; Liu Y; Yu Z; Xu B
    World J Clin Cases; 2024 Jan; 12(1):1-8. PubMed ID: 38292634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM).
    Tanase DM; Gosav EM; Neculae E; Costea CF; Ciocoiu M; Hurjui LL; Tarniceriu CC; Maranduca MA; Lacatusu CM; Floria M; Serban IL
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of gut microbiota on gestational diabetes mellitus: a comprehensive review.
    Huang L; Thonusin C; Chattipakorn N; Chattipakorn SC
    Eur J Nutr; 2021 Aug; 60(5):2343-2360. PubMed ID: 33512587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of gut microbiota by bioactive compounds for prevention and management of type 2 diabetes.
    Sharma BR; Jaiswal S; Ravindra PV
    Biomed Pharmacother; 2022 Aug; 152():113148. PubMed ID: 35665671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes.
    Caesar R
    Can J Diabetes; 2019 Apr; 43(3):224-231. PubMed ID: 30929665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications.
    Zhang L; Chu J; Hao W; Zhang J; Li H; Yang C; Yang J; Chen X; Wang H
    Mediators Inflamm; 2021; 2021():5110276. PubMed ID: 34447287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota and Their Associated Metabolites in Diabetes: A Cross Talk Between Host and Microbes-A Review.
    Safari-Alighiarloo N; Emami Z; Rezaei-Tavirani M; Alaei-Shahmiri F; Razavi S
    Metab Syndr Relat Disord; 2023 Feb; 21(1):3-15. PubMed ID: 36301254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between Gut Microbiota and Oral Antihyperglycemic Drugs: A Systematic Review.
    Mindrescu NM; Guja C; Jinga V; Ispas S; Curici A; Nelson Twakor A; Pantea Stoian AM
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodontitis in elderly patients with type 2 diabetes mellitus: impact on gut microbiota and systemic inflammation.
    Li J; Lu H; Wu H; Huang S; Chen L; Gui Q; Zhou W; Yang Y; Wu Y; Zhang H; Zhang Q; Yang Y
    Aging (Albany NY); 2020 Nov; 12(24):25956-25980. PubMed ID: 33234730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.